Johnny Naoum

Title: Johnny Naoum - Innovator in Somatostatin Prodrugs

Introduction

Johnny Naoum is a notable inventor based in Haifa, Israel. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on somatostatin prodrugs. His research focuses on enhancing the bioavailability and therapeutic efficacy of somatostatin analogs.

Latest Patents

Johnny Naoum holds 1 patent for his invention titled "Somatostatin prodrugs." This patent provides prodrugs of somatostatin peptide and peptide analogs that are tissue permeable and orally bioavailable. The invention enables the activity of the somatostatin analog at circulation or target tissue after the cleavage of charge-masking lipophilic moieties. Additionally, the patent includes pharmaceutical compositions comprising these prodrugs and their applications in therapy and diagnosis.

Career Highlights

Johnny Naoum is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at Yissum has allowed him to explore and develop innovative solutions in the pharmaceutical industry. His research has the potential to impact therapeutic approaches significantly.

Collaborations

Some of Johnny Naoum's notable coworkers include Amnon Hoffman and Chaim Gilon. Their collaborative efforts contribute to the advancement of research and development in their field.

Conclusion

Johnny Naoum's work on somatostatin prodrugs exemplifies the innovative spirit of modern pharmaceutical research. His contributions are paving the way for new therapeutic options and enhancing patient care.